Corient Private Wealth
BVS icon

Corient Private Wealth’s Bioventus BVS Stock Holding History

Corient Private Wealth’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Sell
21,152
-623
-3% -$5.95K ﹤0.01% 2804
2026
Q1 		$199K Buy
21,775
+2,304
+12% +$19.3K ﹤0.01% 2571
2025
Q4 		$145K Buy
19,471
+6,031
+45% +$43.4K ﹤0.01% 2481
2025
Q3 		$89.9K Sell
13,440
-2,153
-14% -$14.9K ﹤0.01% 2459
2025
Q2 		$103K Buy
+15,593
New +$111K ﹤0.01% 2324

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JIC
Juniper Investment Company New York $378M AUM 95.37% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Corient Private Wealth's BVS Position: Q2 2026 in Review

Corient Private Wealth reduced its Bioventus (BVS) stake by 2.9% in Q2 2026, selling an estimated $5.95K and leaving 21,152 shares worth $200K. The position accounts for ﹤0.01% of the portfolio, ranked #2804.

Corient Private Wealth first reported a position in BVS in Q2 2025 and has held it in 5 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q2 2026.

  • Corient Private Wealth held 21,152 shares of Bioventus worth $200K as of Q2 2026.
  • Corient Private Wealth sold 623 Bioventus shares in Q2 2026, an estimated $5.95K.
  • Bioventus made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #2804 holding.
  • Corient Private Wealth first reported a position in Bioventus in Q2 2025 and has held it in 5 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.